Anti-abuse gelled pharmaceutical compositions
AssigneeVitux Group AS
InventorsKurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes, Magnus N. Hattrem
Life of this patent
Estimating the term…
Abstract
This invention provides an oral pharmaceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion containing a drug of abuse.
Claims25
A pharmaceutical composition comprising a physiologically tolerable, flexible, gelled biphasic oil-in-water emulsion containing a drug of abuse which is in a non-prodrug form and which is selected from the group consisting of codeine, morphine, morphine-6-glucuronide, hydrocodone, oxycodone, diamorphine, pethidine, tramadol, buprenorphine, propoxyphene, dextropropoxyphene, hydromorphone, oxymorphone, pentazocine, levorphanol, butorphanol, ketobemidone, fentanyl, meperidine, diphenoxylate, venlafaxine, nefopam, carbamazepine, gabapentin, pregabalin, amitryptiline, pentobarbital sodium, diazepam, alprazolam, flunitrazepam, amphetamine, l-lysine-d-amphetamine, methyl phenidate, methadone, mephedrone, tetrahydrocannabinol, ketamine, clonidine, mexiletine, and tapentadol;
- wherein said composition is in oral, uncoated dose unit form and said dose unit has a weight of 50 to 3000 mg;
- and
- wherein said emulsion has an oil phase and an aqueous phase, said oil phase including a physiologically tolerable lipid, and said aqueous phase including water and a physiologically tolerable gelling agent;
- and
- wherein the weight ratio of the oil phase to the aqueous phase of the emulsion is 1:19 to 3:1.
3-7. (canceled)
A method of preventing abuse of a drug substance which is a drug of abuse, said method comprising the step of formulating said drug substance in a physiologically tolerable gelled oil-in-water emulsion.
Dependencies are inferred from the claim text.